Incidental Mutation 'P0035:Brd4'
ID |
7658 |
Institutional Source |
Beutler Lab
|
Gene Symbol |
Brd4
|
Ensembl Gene |
ENSMUSG00000024002 |
Gene Name |
bromodomain containing 4 |
Synonyms |
WI-11513, HUNK1, MCAP |
MMRRC Submission |
038285-MU
|
Accession Numbers |
|
Essential gene? |
Essential
(E-score: 1.000)
|
Stock # |
P0035 (G1)
|
Quality Score |
|
Status
|
Validated
|
Chromosome |
17 |
Chromosomal Location |
32415248-32503696 bp(-) (GRCm39) |
Type of Mutation |
critical splice donor site (1 bp from exon) |
DNA Base Change (assembly) |
C to T
at 32431812 bp (GRCm39)
|
Zygosity |
Heterozygous |
Amino Acid Change |
|
Ref Sequence |
ENSEMBL: ENSMUSP00000113070
(fasta)
|
Gene Model |
predicted gene model for transcript(s):
[ENSMUST00000003726]
[ENSMUST00000114475]
[ENSMUST00000119123]
[ENSMUST00000120276]
[ENSMUST00000121285]
[ENSMUST00000125899]
[ENSMUST00000127893]
|
AlphaFold |
Q9ESU6 |
Predicted Effect |
probably null
Transcript: ENSMUST00000003726
|
SMART Domains |
Protein: ENSMUSP00000003726 Gene: ENSMUSG00000024002
Domain | Start | End | E-Value | Type |
low complexity region
|
23 |
54 |
N/A |
INTRINSIC |
BROMO
|
56 |
166 |
1e-52 |
SMART |
low complexity region
|
176 |
191 |
N/A |
INTRINSIC |
low complexity region
|
198 |
224 |
N/A |
INTRINSIC |
low complexity region
|
237 |
275 |
N/A |
INTRINSIC |
low complexity region
|
295 |
305 |
N/A |
INTRINSIC |
low complexity region
|
329 |
339 |
N/A |
INTRINSIC |
BROMO
|
352 |
461 |
1.2e-48 |
SMART |
coiled coil region
|
504 |
570 |
N/A |
INTRINSIC |
Pfam:BET
|
611 |
675 |
6.4e-33 |
PFAM |
low complexity region
|
701 |
722 |
N/A |
INTRINSIC |
low complexity region
|
746 |
796 |
N/A |
INTRINSIC |
low complexity region
|
828 |
854 |
N/A |
INTRINSIC |
low complexity region
|
890 |
926 |
N/A |
INTRINSIC |
low complexity region
|
929 |
939 |
N/A |
INTRINSIC |
low complexity region
|
953 |
1005 |
N/A |
INTRINSIC |
low complexity region
|
1013 |
1042 |
N/A |
INTRINSIC |
low complexity region
|
1086 |
1100 |
N/A |
INTRINSIC |
low complexity region
|
1105 |
1120 |
N/A |
INTRINSIC |
low complexity region
|
1135 |
1147 |
N/A |
INTRINSIC |
low complexity region
|
1201 |
1212 |
N/A |
INTRINSIC |
low complexity region
|
1248 |
1260 |
N/A |
INTRINSIC |
coiled coil region
|
1261 |
1345 |
N/A |
INTRINSIC |
Pfam:BRD4_CDT
|
1358 |
1400 |
3.8e-24 |
PFAM |
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000114475
|
SMART Domains |
Protein: ENSMUSP00000110119 Gene: ENSMUSG00000024002
Domain | Start | End | E-Value | Type |
low complexity region
|
23 |
54 |
N/A |
INTRINSIC |
BROMO
|
56 |
166 |
1.67e-50 |
SMART |
low complexity region
|
197 |
223 |
N/A |
INTRINSIC |
low complexity region
|
236 |
274 |
N/A |
INTRINSIC |
low complexity region
|
294 |
304 |
N/A |
INTRINSIC |
low complexity region
|
328 |
338 |
N/A |
INTRINSIC |
BROMO
|
351 |
460 |
1.81e-46 |
SMART |
coiled coil region
|
503 |
569 |
N/A |
INTRINSIC |
PDB:2JNS|A
|
606 |
683 |
3e-46 |
PDB |
low complexity region
|
700 |
720 |
N/A |
INTRINSIC |
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000119123
|
SMART Domains |
Protein: ENSMUSP00000113197 Gene: ENSMUSG00000024002
Domain | Start | End | E-Value | Type |
low complexity region
|
23 |
54 |
N/A |
INTRINSIC |
BROMO
|
56 |
166 |
1.67e-50 |
SMART |
low complexity region
|
197 |
223 |
N/A |
INTRINSIC |
low complexity region
|
236 |
274 |
N/A |
INTRINSIC |
low complexity region
|
294 |
304 |
N/A |
INTRINSIC |
low complexity region
|
328 |
338 |
N/A |
INTRINSIC |
BROMO
|
351 |
460 |
1.81e-46 |
SMART |
coiled coil region
|
503 |
569 |
N/A |
INTRINSIC |
PDB:2JNS|A
|
606 |
683 |
6e-46 |
PDB |
low complexity region
|
700 |
721 |
N/A |
INTRINSIC |
low complexity region
|
745 |
795 |
N/A |
INTRINSIC |
low complexity region
|
827 |
853 |
N/A |
INTRINSIC |
low complexity region
|
889 |
925 |
N/A |
INTRINSIC |
low complexity region
|
928 |
938 |
N/A |
INTRINSIC |
low complexity region
|
952 |
1004 |
N/A |
INTRINSIC |
low complexity region
|
1012 |
1041 |
N/A |
INTRINSIC |
low complexity region
|
1085 |
1099 |
N/A |
INTRINSIC |
low complexity region
|
1104 |
1119 |
N/A |
INTRINSIC |
low complexity region
|
1134 |
1146 |
N/A |
INTRINSIC |
low complexity region
|
1200 |
1211 |
N/A |
INTRINSIC |
low complexity region
|
1247 |
1259 |
N/A |
INTRINSIC |
coiled coil region
|
1260 |
1344 |
N/A |
INTRINSIC |
low complexity region
|
1361 |
1381 |
N/A |
INTRINSIC |
|
Predicted Effect |
probably null
Transcript: ENSMUST00000120276
|
SMART Domains |
Protein: ENSMUSP00000112474 Gene: ENSMUSG00000024002
Domain | Start | End | E-Value | Type |
low complexity region
|
23 |
54 |
N/A |
INTRINSIC |
BROMO
|
56 |
166 |
1.67e-50 |
SMART |
low complexity region
|
197 |
223 |
N/A |
INTRINSIC |
low complexity region
|
236 |
274 |
N/A |
INTRINSIC |
low complexity region
|
294 |
304 |
N/A |
INTRINSIC |
low complexity region
|
328 |
338 |
N/A |
INTRINSIC |
BROMO
|
351 |
460 |
1.81e-46 |
SMART |
coiled coil region
|
503 |
569 |
N/A |
INTRINSIC |
PDB:2JNS|A
|
606 |
683 |
3e-46 |
PDB |
low complexity region
|
700 |
721 |
N/A |
INTRINSIC |
|
Predicted Effect |
probably null
Transcript: ENSMUST00000121285
|
SMART Domains |
Protein: ENSMUSP00000113070 Gene: ENSMUSG00000024002
Domain | Start | End | E-Value | Type |
low complexity region
|
23 |
54 |
N/A |
INTRINSIC |
BROMO
|
56 |
166 |
1.67e-50 |
SMART |
low complexity region
|
197 |
223 |
N/A |
INTRINSIC |
low complexity region
|
236 |
274 |
N/A |
INTRINSIC |
low complexity region
|
294 |
304 |
N/A |
INTRINSIC |
low complexity region
|
328 |
338 |
N/A |
INTRINSIC |
BROMO
|
351 |
460 |
1.81e-46 |
SMART |
coiled coil region
|
503 |
569 |
N/A |
INTRINSIC |
PDB:2JNS|A
|
606 |
683 |
6e-46 |
PDB |
low complexity region
|
700 |
721 |
N/A |
INTRINSIC |
low complexity region
|
745 |
795 |
N/A |
INTRINSIC |
low complexity region
|
827 |
853 |
N/A |
INTRINSIC |
low complexity region
|
889 |
925 |
N/A |
INTRINSIC |
low complexity region
|
928 |
938 |
N/A |
INTRINSIC |
low complexity region
|
952 |
1004 |
N/A |
INTRINSIC |
low complexity region
|
1012 |
1041 |
N/A |
INTRINSIC |
low complexity region
|
1085 |
1099 |
N/A |
INTRINSIC |
low complexity region
|
1104 |
1119 |
N/A |
INTRINSIC |
low complexity region
|
1134 |
1146 |
N/A |
INTRINSIC |
low complexity region
|
1200 |
1211 |
N/A |
INTRINSIC |
low complexity region
|
1247 |
1259 |
N/A |
INTRINSIC |
coiled coil region
|
1260 |
1344 |
N/A |
INTRINSIC |
low complexity region
|
1361 |
1381 |
N/A |
INTRINSIC |
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000125899
|
SMART Domains |
Protein: ENSMUSP00000115277 Gene: ENSMUSG00000024002
Domain | Start | End | E-Value | Type |
low complexity region
|
23 |
54 |
N/A |
INTRINSIC |
BROMO
|
56 |
144 |
5.02e-31 |
SMART |
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000127893
|
SMART Domains |
Protein: ENSMUSP00000115163 Gene: ENSMUSG00000024002
Domain | Start | End | E-Value | Type |
low complexity region
|
23 |
54 |
N/A |
INTRINSIC |
BROMO
|
56 |
166 |
1.67e-50 |
SMART |
low complexity region
|
197 |
223 |
N/A |
INTRINSIC |
low complexity region
|
236 |
274 |
N/A |
INTRINSIC |
low complexity region
|
294 |
304 |
N/A |
INTRINSIC |
low complexity region
|
328 |
338 |
N/A |
INTRINSIC |
BROMO
|
351 |
460 |
1.81e-46 |
SMART |
coiled coil region
|
503 |
531 |
N/A |
INTRINSIC |
low complexity region
|
536 |
557 |
N/A |
INTRINSIC |
|
Meta Mutation Damage Score |
0.9597 |
Coding Region Coverage |
- 1x: 79.0%
- 3x: 68.4%
- 10x: 37.5%
- 20x: 15.8%
|
Validation Efficiency |
82% (103/125) |
MGI Phenotype |
FUNCTION: This gene was temporarily named bromodomain-containing 5 (Brd5) and was renamed bromodomain-containing 4 (Brd4). [provided by RefSeq, Jul 2008] PHENOTYPE: Homozygotes for a gene-trap null mutation die soon after implantation. Heterozygotes exhibit impaired pre- and postnatal growth, head malformations, lack of subcutaneous fat, cataracts, and abnormal liver cells. [provided by MGI curators]
|
Allele List at MGI |
All alleles(161) : Targeted(1) Gene trapped(160)
|
Other mutations in this stock |
Total: 18 list
Gene | Ref | Var | Chr/Loc | Mutation | Predicted Effect | Zygosity |
Bub1b |
G |
A |
2: 118,452,666 (GRCm39) |
E440K |
probably damaging |
Het |
Cfap70 |
A |
G |
14: 20,474,539 (GRCm39) |
|
probably benign |
Het |
Cryba2 |
A |
G |
1: 74,929,171 (GRCm39) |
S191P |
probably damaging |
Het |
Dsg3 |
A |
C |
18: 20,673,026 (GRCm39) |
N899T |
probably benign |
Het |
Htr2b |
A |
T |
1: 86,038,452 (GRCm39) |
H51Q |
probably benign |
Het |
Lmod2 |
T |
C |
6: 24,597,885 (GRCm39) |
S2P |
probably damaging |
Het |
Lrrc37a |
T |
A |
11: 103,393,958 (GRCm39) |
E489V |
possibly damaging |
Het |
Mdn1 |
A |
T |
4: 32,749,934 (GRCm39) |
Q4372H |
probably benign |
Het |
Med13l |
C |
T |
5: 118,880,685 (GRCm39) |
T1259I |
probably benign |
Het |
Muc4 |
T |
C |
16: 32,580,622 (GRCm39) |
|
probably benign |
Het |
Pcsk2 |
C |
T |
2: 143,637,871 (GRCm39) |
T369I |
probably damaging |
Het |
Pggt1b |
G |
C |
18: 46,392,787 (GRCm39) |
H121Q |
probably damaging |
Het |
Pkhd1 |
T |
C |
1: 20,187,571 (GRCm39) |
D3579G |
probably benign |
Het |
Psd |
T |
C |
19: 46,309,400 (GRCm39) |
E520G |
possibly damaging |
Het |
Scfd2 |
A |
T |
5: 74,385,980 (GRCm39) |
M613K |
possibly damaging |
Het |
Tbc1d32 |
A |
C |
10: 56,074,535 (GRCm39) |
F226C |
probably damaging |
Het |
Ttc8 |
T |
C |
12: 98,942,675 (GRCm39) |
|
probably benign |
Het |
Zfp462 |
T |
C |
4: 55,009,086 (GRCm39) |
S351P |
probably benign |
Het |
|
Other mutations in Brd4 |
Allele | Source | Chr | Coord | Type | Predicted Effect | PPH Score |
IGL01736:Brd4
|
APN |
17 |
32,417,649 (GRCm39) |
splice site |
probably benign |
|
IGL01758:Brd4
|
APN |
17 |
32,431,803 (GRCm39) |
unclassified |
probably benign |
|
IGL02750:Brd4
|
APN |
17 |
32,417,353 (GRCm39) |
unclassified |
probably benign |
|
IGL03066:Brd4
|
APN |
17 |
32,418,062 (GRCm39) |
intron |
probably benign |
|
IGL03338:Brd4
|
APN |
17 |
32,432,046 (GRCm39) |
missense |
probably damaging |
1.00 |
Admirable
|
UTSW |
17 |
32,444,557 (GRCm39) |
missense |
unknown |
|
H8562:Brd4
|
UTSW |
17 |
32,448,377 (GRCm39) |
splice site |
probably benign |
|
R0243:Brd4
|
UTSW |
17 |
32,443,097 (GRCm39) |
missense |
probably benign |
0.15 |
R0281:Brd4
|
UTSW |
17 |
32,432,514 (GRCm39) |
unclassified |
probably benign |
|
R0331:Brd4
|
UTSW |
17 |
32,421,489 (GRCm39) |
missense |
probably benign |
0.01 |
R0722:Brd4
|
UTSW |
17 |
32,431,956 (GRCm39) |
missense |
possibly damaging |
0.76 |
R0750:Brd4
|
UTSW |
17 |
32,439,226 (GRCm39) |
missense |
probably benign |
0.09 |
R1544:Brd4
|
UTSW |
17 |
32,417,646 (GRCm39) |
splice site |
probably benign |
|
R1920:Brd4
|
UTSW |
17 |
32,417,060 (GRCm39) |
unclassified |
probably benign |
|
R1922:Brd4
|
UTSW |
17 |
32,417,060 (GRCm39) |
unclassified |
probably benign |
|
R1957:Brd4
|
UTSW |
17 |
32,440,340 (GRCm39) |
missense |
possibly damaging |
0.50 |
R2240:Brd4
|
UTSW |
17 |
32,432,613 (GRCm39) |
unclassified |
probably benign |
|
R2316:Brd4
|
UTSW |
17 |
32,431,884 (GRCm39) |
missense |
probably benign |
0.03 |
R2333:Brd4
|
UTSW |
17 |
32,440,431 (GRCm39) |
missense |
probably damaging |
0.97 |
R3809:Brd4
|
UTSW |
17 |
32,430,244 (GRCm39) |
missense |
possibly damaging |
0.72 |
R4273:Brd4
|
UTSW |
17 |
32,433,756 (GRCm39) |
missense |
probably benign |
|
R4595:Brd4
|
UTSW |
17 |
32,417,896 (GRCm39) |
missense |
probably damaging |
0.97 |
R4854:Brd4
|
UTSW |
17 |
32,439,211 (GRCm39) |
missense |
probably damaging |
0.96 |
R4923:Brd4
|
UTSW |
17 |
32,418,214 (GRCm39) |
missense |
probably benign |
0.38 |
R5014:Brd4
|
UTSW |
17 |
32,417,372 (GRCm39) |
unclassified |
probably benign |
|
R5757:Brd4
|
UTSW |
17 |
32,420,272 (GRCm39) |
unclassified |
probably benign |
|
R5979:Brd4
|
UTSW |
17 |
32,417,700 (GRCm39) |
missense |
probably benign |
0.32 |
R6212:Brd4
|
UTSW |
17 |
32,421,423 (GRCm39) |
missense |
probably damaging |
0.98 |
R6394:Brd4
|
UTSW |
17 |
32,443,121 (GRCm39) |
nonsense |
probably null |
|
R6643:Brd4
|
UTSW |
17 |
32,417,470 (GRCm39) |
missense |
unknown |
|
R7024:Brd4
|
UTSW |
17 |
32,440,884 (GRCm39) |
utr 3 prime |
probably benign |
|
R7033:Brd4
|
UTSW |
17 |
32,417,989 (GRCm39) |
missense |
probably benign |
0.13 |
R7220:Brd4
|
UTSW |
17 |
32,444,557 (GRCm39) |
missense |
unknown |
|
R7682:Brd4
|
UTSW |
17 |
32,420,134 (GRCm39) |
missense |
unknown |
|
R7731:Brd4
|
UTSW |
17 |
32,430,198 (GRCm39) |
missense |
possibly damaging |
0.73 |
R7732:Brd4
|
UTSW |
17 |
32,440,386 (GRCm39) |
missense |
unknown |
|
R7750:Brd4
|
UTSW |
17 |
32,432,521 (GRCm39) |
missense |
unknown |
|
R7756:Brd4
|
UTSW |
17 |
32,417,956 (GRCm39) |
missense |
unknown |
|
R7758:Brd4
|
UTSW |
17 |
32,417,956 (GRCm39) |
missense |
unknown |
|
R7779:Brd4
|
UTSW |
17 |
32,431,910 (GRCm39) |
missense |
probably benign |
0.03 |
R8214:Brd4
|
UTSW |
17 |
32,431,921 (GRCm39) |
missense |
probably benign |
0.19 |
R8405:Brd4
|
UTSW |
17 |
32,448,505 (GRCm39) |
missense |
unknown |
|
R9675:Brd4
|
UTSW |
17 |
32,433,786 (GRCm39) |
missense |
unknown |
|
X0064:Brd4
|
UTSW |
17 |
32,420,101 (GRCm39) |
unclassified |
probably benign |
|
|
Nature of Mutation |
Multiple transcripts of the Brd4 gene are displayed on Ensembl.
|
Protein Function and Prediction |
The Brd4 gene encodes multiple isoforms of a nuclear protein that plays a role in a process governing chromosomal dynamics during mitosis. The standard isoform contains 1400 amino acids and has two bromo domains at residues 75-147 and 369-441 that associate with chromatin (Uniprot Q9ESU6). Brd4 is a member of the BET family of nuclear proteins and is proposed to have a role in chromosomal dynamics during mitosis (1) by binding preferentially to acetylated chromatin. Further studies identified Brd4 as a component of the E2 chromosomal attachment complex (2). Brd4 can function in both gene activation and repression [reviewed in (3)]. Inhibition of Brd4 function by exposure to anti-Brd4 antibodies can lead to G2/M arrest (1); overexpression leads to G1/S arrest (4).
|
Expression/Localization |
Northern blot of mouse and human tissues found that Brd4 is ubiquitously expressed (1;5). Immunofluoresence detected the Brd4 protein in the nucleus and in mitotic cells Brd4 is almost exclusively at condensed chromosomes (1).
|
Background |
Brd4Gt(pGT1.8TM)ST132Nimr/ Gt(pGT1.8TM)ST132Nimr; MGI:2674141
involves: 129P2/Ola * C57BL/6J
Homozygotes for a gene-trap null mutation die soon after implantation (6). Heterozygotes exhibit impaired pre- and postnatal growth, head malformations, lack of subcutaneous fat, cataracts, and abnormal liver cells (6).
|
References |
1. Dey, A., Ellenberg, J., Farina, A., Coleman, A. E., Maruyama, T., Sciortino, S., Lippincott-Schwartz, J., and Ozato, K. (2000) A Bromodomain Protein, MCAP, Associates with Mitotic Chromosomes and Affects G(2)-to-M Transition. Mol Cell Biol. 20, 6537-6549.
2. You, J., Croyle, J. L., Nishimura, A., Ozato, K., and Howley, P. M. (2004) Interaction of the Bovine Papillomavirus E2 Protein with Brd4 Tethers the Viral DNA to Host Mitotic Chromosomes. Cell. 117, 349-360.
4. Maruyama, T., Farina, A., Dey, A., Cheong, J., Bermudez, V. P., Tamura, T., Sciortino, S., Shuman, J., Hurwitz, J., and Ozato, K. (2002) A Mammalian Bromodomain Protein, brd4, Interacts with Replication Factor C and Inhibits Progression to S Phase. Mol Cell Biol. 22, 6509-6520.
5. French, C. A., Miyoshi, I., Kubonishi, I., Grier, H. E., Perez-Atayde, A. R., and Fletcher, J. A. (2003) BRD4-NUT Fusion Oncogene: A Novel Mechanism in Aggressive Carcinoma. Cancer Res. 63, 304-307.
6. Houzelstein, D., Bullock, S. L., Lynch, D. E., Grigorieva, E. F., Wilson, V. A., and Beddington, R. S. (2002) Growth and Early Postimplantation Defects in Mice Deficient for the Bromodomain-Containing Protein Brd4. Mol Cell Biol. 22, 3794-3802.
|
Posted On |
2012-10-29 |
Science Writer |
Anne Murray |